FDA
-
-
-
-
-
-
-
GW Pharmaceuticals and U.S. Subsidiary Greenwich Biosciences to Present Data at the 2021 American Academy of Neurology (AAN) Annual Meeting
-
-
-
-
-
-
-
GW Pharmaceuticals Provides Preliminary Fourth Quarter and Full-Year 2020 Net Product Sales Results and 2021 Program Milestones
-
-
-
-
-
-
-
GW Pharmaceuticals to Present at the Evercore ISI 2020 Healthcare Conference
-
-
-
-
-
-
-
Greenwich Biosciences, Inc., a Subsidiary of GW Pharmaceuticals plc, Launches unspoken symphony, a Breakthrough Innovation Created for the US Epilepsy Community
-
-
-
-
-
-
-
GW Pharmaceuticals plc Reports Second Quarter 2020 Financial Results and Operational Progress
-
-
-
-
-
-
-
GW Pharma (GWPH) Reports EPIDYOLEX (cannabidiol) Reclassified by UK Home Office as Schedule 5 Drug
-
-
-
-
-
-
-
GW Pharmaceuticals to Present at the Bank of America Healthcare Conference 2020
-
312,667 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

